GLI1 upregulates C-JUN through a specific 130-kDa isoform

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 655-661

  Amable, Lauren ^a   Gavin, Elaine ^b   Kudo, Kenji ^b   Meng, Erhong ^b   Rocconi, Rodney P ^b   Shevde, Lalita A ^c   Reed, Eddie ^a  

^a NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

AP1; C JUN; Cisplatin resistance; GLI1; Hedgehog

Indexed keywords

CISPLATIN; PROTEIN C JUN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER TISSUE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; SOUTHWESTERN BLOTTING; TRANSCRIPTION REGULATION; UPREGULATION;

CISPLATIN; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; FEMALE; HEDGEHOG PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; PROTEIN ISOFORMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 85047688102     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2222     Document Type: Article

References (26)

1. Liao X, Siu MK, Au CW, et al: Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30: 131-140, 2009.
2. Chen X, Horiuchi A, Kikuchi N, et al: Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis. Cancer Sci 98: 68-76, 2007. (Pubitemid 44803922)
3. Ray A, Meng E, Reed E, Shevde LA and Rocconi RP: Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. Int J Oncol 39: 797-804, 2011.
4. Mas C and Ruiz i Altaba A: Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations. Biochem Pharmacol 80: 712-723, 2010.
5. Stecca B and Ruiz IAA: Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2: 84-95, 2010.
6. Zhu H and Lo HW: The human glioma-associated oncogene homolog 1 (GLI1) family of transcription factors in gene regulation and diseases. Curr Genomics 11: 238-245, 2010.
7. Mine T, Matsueda S, Gao H, et al: Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells. Oncol Rep 23: 1537-1543, 2010.
8. Steg AD, Bevis KS, Katre AA, et al: Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 18: 869-881, 2012.
9. Kudo K, Gavin E, Das S, Amable L, Shevde LA and Reed E: Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1 and inhibition of platinum-DNA adduct repair. Oncogene 31: 4718-4724, 2012.
10. Zhong X, Thornton K and Reed E: Computer based analyses of the 5′-flanking regions of selected genes involved in the nucleotide excision repair complex. Int J Oncol 17: 375-380, 2000.
11. Bonovich M, Olive M, Reed E, O'Connell B and Vinson C: Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines. Cancer Gene Ther 9: 62-70, 2002. (Pubitemid 34052855)
12. Li Q, Tsang B, Bostick-Bruton F and Reed E: Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells. Biochem Pharmacol 57: 347-353, 1999. (Pubitemid 29065282)
13. Reed E: ERCC1 measurements in clinical oncology. N Engl J Med 355: 1054-1055, 2006.
14. Reed E: DNA damage and repair in translational oncology: an overview. Clin Cancer Res 16: 4511-4516, 2010.
15. Laner-Plamberger S, Kaser A, Paulischta M, Hauser-Kronberger C, Eichberger T and Frischauf AM: Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes. Oncogene 28: 1639-1651, 2009.
16. Li Q, Gardner K, Zhang L, Tsang B, Bostick-Bruton F and Reed E: Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells. J Biol Chem 273: 23419-23425, 1998. (Pubitemid 28417531)
17. Raivich G: c-Jun expression, activation and function in neural cell death, inflammation and repair. J Neurochem 107: 898-906, 2008.
18. Stecca B and Ruiz i Altaba A: A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 28: 663-676, 2009.
19. Cheng CK, Yeung CM, Hoo RL, Chow BK and Leung PC: Oct-1 is involved in the transcriptional repression of the gonadotropin-releasing hormone receptor gene. Endocrinology 143: 4693-4701, 2002. (Pubitemid 35397611)
20. Ruiz i Altaba A: Gli proteins encode context-dependent positive and negative functions: implications for development and disease. Development 126: 3205-3216, 1999.
21. Ruiz i Altaba A: Hedgehog signaling and the Gli code in stem cells, cancer and metastases. Sci Signal 4: pt9, 2011.
22. Carpenter RL and Lo HW: Identification, functional characterization and pathobiological significance of GLI1 isoforms in human cancers. Vitam Horm 88: 115-140, 2012.
23. Carpenter RL and Lo HW: Hedgehog pathway and GLI1 isoforms in human cancer. Discov Med 13: 105-113, 2012.
24. Lo HW, Zhu H, Cao X, Aldrich A and Ali-Osman F: A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Res 69: 6790-6798, 2009.
25. Agyeman A, Mazumdar T and Houghton JA: Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer. Oncotarget 3: 854-868, 2012.
26. Leonard JM, Ye H, Wetmore C and Karnitz LM: Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability. J Cell Biol 183: 385-391, 2008.